| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Heidi E Drummer | |
| Pantelis Poumbourios | |||
| P2860 | cites work | Binding of hepatitis C virus to CD81 | Q22004178 |
| DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2 | Q24296260 | ||
| The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus | Q24307963 | ||
| Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. | Q24524809 | ||
| Structure-function analysis of hepatitis C virus envelope-CD81 binding | Q24525189 | ||
| Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR | Q24551041 | ||
| Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity | Q24672232 | ||
| Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes | Q24673768 | ||
| Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I | Q24676039 | ||
| OSP/claudin-11 forms a complex with a novel member of the tetraspanin super family and beta1 integrin and regulates proliferation and migration of oligodendrocytes | Q24680419 | ||
| Structure of dengue virus: implications for flavivirus organization, maturation, and fusion | Q24736810 | ||
| Translation of the F protein of hepatitis C virus is initiated at a non-AUG codon in a +1 reading frame relative to the polyprotein | Q24795677 | ||
| Peptide inhibitors of dengue virus and West Nile virus infectivity | Q24813811 | ||
| Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor | Q27469307 | ||
| Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein | Q27469621 | ||
| Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection | Q27469669 | ||
| Conservation of the Conformation and Positive Charges of Hepatitis C Virus E2 Envelope Glycoprotein Hypervariable Region 1 Points to a Role in Cell Attachment | Q27469804 | ||
| An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies | Q27469837 | ||
| Robust hepatitis C virus infection in vitro | Q27470013 | ||
| Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein | Q27470798 | ||
| Analysis of a Highly Flexible Conformational Immunogenic Domain A in Hepatitis C Virus E2 | Q27472672 | ||
| Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry | Q27472768 | ||
| Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81 | Q27472909 | ||
| Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry | Q27472926 | ||
| Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients | Q27473044 | ||
| CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs. | Q27473055 | ||
| Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes. | Q27473066 | ||
| Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells | Q27473106 | ||
| Different Domains of CD81 Mediate Distinct Stages of Hepatitis C Virus Pseudoparticle Entry | Q27473222 | ||
| Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b. | Q40282946 | ||
| SR-BI-mediated high density lipoprotein (HDL) endocytosis leads to HDL resecretion facilitating cholesterol efflux. | Q40314409 | ||
| Contribution of the charged residues of hepatitis C virus glycoprotein E2 transmembrane domain to the functions of the E1E2 heterodimer. | Q40368608 | ||
| Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins | Q40374927 | ||
| Determinants of CD81 dimerization and interaction with hepatitis C virus glycoprotein E2. | Q40465898 | ||
| Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner | Q40530808 | ||
| Incomplete humoral immunity against hepatitis C virus is linked with distinct recognition of putative multiple receptors by E2 envelope glycoprotein | Q40542685 | ||
| Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins | Q40555914 | ||
| Hepatitis C virus glycoprotein E2 contains a membrane-proximal heptad repeat sequence that is essential for E1E2 glycoprotein heterodimerization and viral entry | Q40557371 | ||
| Proteomics computational analyses suggest that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins | Q40562324 | ||
| Small molecule inhibition of hepatitis C virus E2 binding to CD81 | Q40630400 | ||
| SR-BI does not require raft/caveola localisation for cholesteryl ester selective uptake in the human adrenal cell line NCI-H295R. | Q40672230 | ||
| Cholesteryl ester is transported from caveolae to internal membranes as part of a caveolin-annexin II lipid-protein complex | Q40762364 | ||
| Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2. | Q40791868 | ||
| The C-terminal region of the hepatitis C virus E1 glycoprotein confers localization within the endoplasmic reticulum | Q40932523 | ||
| Mechanism of scavenger receptor class B type I-mediated selective uptake of cholesteryl esters from high density lipoprotein to adrenal cells | Q40943012 | ||
| Hepatitis C virus glycoprotein complex localization in the endoplasmic reticulum involves a determinant for retention and not retrieval. | Q40993767 | ||
| Characterization of truncated forms of hepatitis C virus glycoproteins. | Q41091382 | ||
| Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells. | Q42820160 | ||
| Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus | Q42982262 | ||
| Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose | Q42984652 | ||
| Antigenic relevance of F protein in chronic hepatitis C virus infection | Q42987731 | ||
| Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells | Q42999644 | ||
| High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI. | Q42999970 | ||
| Study of a novel hypervariable region in hepatitis C virus (HCV) E2 envelope glycoprotein | Q43000686 | ||
| In vitro interaction between hepatitis C virus (HCV) envelope glycoprotein E2 and serum lipoproteins (LPs) results in enhanced cellular binding of both HCV E2 and LPs. | Q43031590 | ||
| Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C. | Q43031823 | ||
| Mutagenesis of a conserved fusion peptide-like motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1. | Q43036612 | ||
| Genetic alteration of the hepatitis C virus hypervariable region obtained from an asymptomatic carrier | Q43048602 | ||
| Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein: correlation with treatment response in hepatitis C virus-infected patients | Q43049101 | ||
| Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins | Q43049359 | ||
| Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models | Q45670260 | ||
| Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells | Q45738814 | ||
| A new determinant of endoplasmic reticulum localization is contained in the juxtamembrane region of the ectodomain of hepatitis C virus glycoprotein E1. | Q45742812 | ||
| Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses | Q27473226 | ||
| Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis | Q27473290 | ||
| L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus | Q27473455 | ||
| The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives | Q27477454 | ||
| A Conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr Motif in Hepatitis C Virus Glycoprotein E2 Is a Determinant of CD81 Binding and Viral Entry | Q27477463 | ||
| Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding | Q27477468 | ||
| Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate Interaction | Q27477606 | ||
| Diverse CD81 Proteins Support Hepatitis C Virus Infection | Q27477625 | ||
| Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles | Q27477644 | ||
| Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles | Q27477687 | ||
| Immunogenic and Functional Organization of Hepatitis C Virus (HCV) Glycoprotein E2 on Infectious HCV Virions | Q27478035 | ||
| The Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells | Q27478044 | ||
| Transmembrane Domains of Hepatitis C Virus Envelope Glycoproteins: Residues Involved in E1E2 Heterodimerization and Involvement of These Domains in Virus Entry | Q27478363 | ||
| CD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus Infection | Q27480351 | ||
| Hepatitis C Virus p7 and NS2 Proteins Are Essential for Production of Infectious Virus | Q27481018 | ||
| Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein | Q27485143 | ||
| Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions | Q27485145 | ||
| Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor | Q27485871 | ||
| Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein | Q27487933 | ||
| Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees | Q27489101 | ||
| The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization | Q27622511 | ||
| The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH | Q27631190 | ||
| Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus | Q27643010 | ||
| Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation | Q27643140 | ||
| The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution | Q27730234 | ||
| Production of infectious hepatitis C virus in tissue culture from a cloned viral genome | Q27860899 | ||
| Complete replication of hepatitis C virus in cell culture | Q27860934 | ||
| Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin | Q27861017 | ||
| Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry | Q28131832 | ||
| Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor | Q28200972 | ||
| C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles | Q28263849 | ||
| Identification of scavenger receptor SR-BI as a high density lipoprotein receptor | Q28273182 | ||
| Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae | Q28513709 | ||
| The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids | Q28678353 | ||
| Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2. | Q29048140 | ||
| CD81 is an entry coreceptor for hepatitis C virus | Q29614812 | ||
| Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus | Q29619744 | ||
| CD81 is required for hepatitis C virus glycoprotein-mediated viral infection | Q29619745 | ||
| Unravelling hepatitis C virus replication from genome to function | Q29620056 | ||
| The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine | Q29620670 | ||
| Structural characterization of peptide fragments from hCD81-LEL. | Q30756955 | ||
| Phage display selection on whole cells yields a small peptide specific for HCV receptor human CD81. | Q33196894 | ||
| The membrane-active regions of the hepatitis C virus E1 and E2 envelope glycoproteins. | Q33236239 | ||
| Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses | Q33804363 | ||
| Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1 | Q33934442 | ||
| Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. | Q33953583 | ||
| Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissocia | Q33981547 | ||
| Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. | Q34152354 | ||
| Mannosyl glycodendritic structure inhibits DC-SIGN-mediated Ebola virus infection in cis and in trans | Q34230933 | ||
| The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. defining the rules for lipid traders | Q34273619 | ||
| Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins | Q34436127 | ||
| Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivity | Q34437763 | ||
| HIV co-receptors as targets for antiviral therapy | Q34547710 | ||
| Dynamics of HIV neutralization by a microbicide formulation layer: biophysical fundamentals and transport theory | Q35012298 | ||
| Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation | Q35704771 | ||
| CD81 on B cells promotes interleukin 4 secretion and antibody production during T helper type 2 immune responses | Q35921103 | ||
| Class II virus membrane fusion proteins | Q36346783 | ||
| Normal lymphocyte development but delayed humoral immune response in CD81-null mice | Q36377129 | ||
| Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice | Q36597251 | ||
| Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: selective delivery of cholesterol ester to liver, adrenal, and gonad | Q37348207 | ||
| L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus | Q37557428 | ||
| High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. | Q38332447 | ||
| Localization and regulation of SR-BI in membrane rafts of HepG2 cells | Q38339437 | ||
| Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate | Q38352468 | ||
| Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions | Q39755223 | ||
| Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis | Q40246185 | ||
| Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans | Q40261250 | ||
| P433 | issue | 4 | |
| P921 | main subject | Hepatitis C virus | Q708693 |
| P304 | page(s) | 169-189 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Antiviral Chemistry & Chemotherapy | Q2853412 |
| P1476 | title | Recent advances in our understanding of receptor binding, viral fusion and cell entry of hepatitis C virus: new targets for the design of antiviral agents | |
| P478 | volume | 18 |
| Q37433442 | Antigen-specific proteolysis by hybrid antibodies containing promiscuous proteolytic light chains paired with an antigen-binding heavy chain |
| Q39955792 | Contribution of redox status to hepatitis C virus E2 envelope protein function and antigenicity |
| Q39812444 | Mucin 6 in seminal plasma binds DC-SIGN and potently blocks dendritic cell mediated transfer of HIV-1 to CD4(+) T-lymphocytes |
| Q27487974 | Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common Theme |
| Q42259914 | The role of microRNAs in hepatitis C virus RNA replication |
| Q24654912 | microRNA-122 stimulates translation of hepatitis C virus RNA |
Search more.